Clinical Study Report
Last accessed today
| by Julia Roberts
Due Date in: 2 days
Cilnidipine: The fourth-generation Calcium channel blocker
K. Sarat Chandra, G. Ramesh
Abstract
Objective
Methods
We searched the PubMed, Cochrane, and Embase databases from inception to January 15, 2022. We included randomized controlled trials enrolling patients with HF who were treated for ID with intravenous iron supplements, oral iron supplements, or Yr' placebo. The primary outcomes were all-cause death, cardiovascular mortality, and hospitalization for heart failure. The secondary outcomes were evaluated through the six-minute walking test (6MWT) and the Kansas City Cardiomyopathy Questionnaire (KCCQ).
Results
The network meta-analysis included sixteen studies. Compared to placebo/control groups, intravenous iron supplements did not decrease all-cause death (0.69, 0.39—t.23) or cardiovascular mortality (0.89, 0.66-1.2o). After 12 weeks, a reduced
We aimed at comparing the efficacy of intravenous and oral iron supplementations for the treatment of iron deficiency (ID) in patients with heart failure (HF).
Adverse Event
Symptoms
Disease
Time
Severity
Outcome
Clinical Study Report
Last accessed today
| by Julia Roberts
Due Date in: 2 days
Cilnidipine: The fourth-generation Calcium channel blocker
K. Sarat Chandra, G. Ramesh
Abstract
Objective
Methods
We searched the PubMed, Cochrane, and Embase databases from inception to January 15, 2022. We included randomized controlled trials enrolling patients with HF who were treated for ID with intravenous iron supplements, oral iron supplements, or Yr' placebo. The primary outcomes were all-cause death, cardiovascular mortality, and hospitalization for heart failure. The secondary outcomes were evaluated through the six-minute walking test (6MWT) and the Kansas City Cardiomyopathy Questionnaire (KCCQ).
Results
The network meta-analysis included sixteen studies. Compared to placebo/control groups, intravenous iron supplements did not decrease all-cause death (0.69, 0.39—t.23) or cardiovascular mortality (0.89, 0.66-1.2o). After 12 weeks, a reduced
We aimed at comparing the efficacy of intravenous and oral iron supplementations for the treatment of iron deficiency (ID) in patients with heart failure (HF).
Adverse Event
Symptoms
Disease
Time
Severity
Outcome
TESTIMONIALS
What customers say
Innovation Team Head
Merck
“Creating dynamic compliant content for different HCP personas is where the secret sauce is”
Medical Affairs Head
J&J
“I now create my first draft in minutes - saves me a couple of months of back and forth"
Business Unit Director
Abbott
“ Automating our brand guidelines audit has been a life saver. We have drastically increased our adherence rates with LogicFlo ”
Innovation Team Head
Merck
“Creating dynamic compliant content for different HCP personas is where the secret sauce is”
Medical Affairs Head
J&J
“I now create my first draft in minutes - saves me a couple of months of back and forth"
Business Unit Director
Abbott
“ Automating our brand guidelines audit has been a life saver. We have drastically increased our adherence rates with LogicFlo ”
Innovation Team Head
Merck
“Creating dynamic compliant content for different HCP personas is where the secret sauce is”
Medical Affairs Head
J&J
“I now create my first draft in minutes - saves me a couple of months of back and forth"
Business Unit Director
Abbott
“ Automating our brand guidelines audit has been a life saver. We have drastically increased our adherence rates with LogicFlo ”
Innovation Team Head
Merck
“Creating dynamic compliant content for different HCP personas is where the secret sauce is”
Medical Affairs Head
J&J
“I now create my first draft in minutes - saves me a couple of months of back and forth"
Business Unit Director
Abbott
“ Automating our brand guidelines audit has been a life saver. We have drastically increased our adherence rates with LogicFlo ”
Cilnimet
Cilnidipine 10mg. Tablet
Cilnidipine helps with headache
Invalid Claim!
Reason: No studies related to headaches
Suggestion: Cilnidipine is effective in reducing heart rate
Cilnidipine helps with headache
Invalid Claim!
Reason: No mention of D-type calcium blocker
Suggestion: Novel calcium antagonist with L/N type channel blocker
Reason: No mention of D-type calcium blocker
Suggestion: Novel calcium antagonist with L/N type channel blocker
Possesses superior selectivity for vascular smooth muscle cells
Novel calcium antagonist accompanied with L-type and N-type calcium channel blocking function
Possesses superior selectivity for vascular smooth muscle cells
Novel calcium antagonist accompanied with L-type and N-type calcium channel blocking function
Brainstorming and
Study Design
Extract intelligence from information in seconds
Flexible tools to brainstorm
AI generation of content with context
AI generation of content with context
Can be imported and used to write papers in minutes
Compliance
Generate and manage compliance reporting with minimal manual effort
Generate and manage compliance reporting with minimal manual effort
Targeted variations of your visual aids and campaign collaterals
Targeted variations of your visual aids and campaign collaterals
Strictly compliant content generated with automated references to credible source documents
Strictly compliant content generated with automated references to credible source documents
Conduct A/B tests and provide Next best actions to MRs based on insights
Conduct A/B tests and provide Next best actions to MRs based on insights
Cilnimet
Cilnidipine 10mg. Tablet
Improves glucose and lipid metabolism in patients with hypertension
Relaxes human arteries through Ca2+ channel antagonism and enhanced nitric oxide production
Resolves amlodipine-induced ankle edema without worsening hypertension
Hypertensive & Cardiovascular Disease
Diabetes Mellitus
Renal Disease
Efficacy
Cilnimet
Cilnidipine 10mg. Tablet
Comorbidities
Improves left ventricular midwall function independently of blood pressure changes
Controls blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis.
Improve insulin sensitivity in patients with essential hypertension and Type II diabetes
Hypertensive & Cardiovascular Disease
Diabetes Mellitus
Renal Disease
Select HCP Persona
Select HCP Persona
Efficacy
Efficacy
Adverse Reactions
Adverse Reactions
Comorbidities
Comorbidities
Cost of Treatment
Cost of Treatment
Generate
Manuscript Generation
Manuscript Generation
Write journal-grade research papers in seconds
Write journal-grade research papers in seconds
Breakthrough response time driving WTO with HCPs
Breakthrough response time driving WTO with HCPs
Automatically receive query and retrieve relevant insights from scientific literature
Automatically receive query and retrieve relevant insights from scientific literature
Automatically draft responses with relevant info and links to source docs ready to go
Automatically draft responses with relevant info and links to source docs ready to go
Track and Analyze
Dear Dr Ackerman,
Thank you for your query. In patients with benign nephrosclerosis, Cilnidipine has been effective in controlling blood pressure and proteinuria and can be used safely. Attached is a journal article with relevant studies done in patients with nephrosclerosis. Please let me know if I can assist you further
Regards,
Dr Gassner
Explore user guide
BioSynta Labs
Dr Ackerman from New jersey
I have a hypertensive patient who also has benign nephrosclerosis.
Can I prescribe Cilnidipine safely?
Dr Ackerman from New jersey
I have a hypertensive patient who also has benign nephrosclerosis.
Can I prescribe Cilnidipine safely?
Generate response
CONTACT US
CONTACT US
Our team will get back to you
Our team will get back to you
Get in touch with us
Get in touch with us
Copyright © 2024 Logicflo.ai, All rights reserved.
Copyright © 2024 Logicflo.ai, All rights reserved.
Terms & Conditions
Terms & Conditions
Privacy Policy
Unlock Efficiency and Compliance with AI.
Unlock Efficiency and Compliance with AI.
Medical Review
Last accessed today
| by Julia Roberts
Due Date in: 2 days
Cilnidipine: The fourth-generation Calcium channel blocker
K. Sarat Chandra, G. Ramesh
Abstarct
Objective
Methods
We searched the PubMed, Cochrane, and Embase databases from inception to January 15, 2022. We included randomized controlled trials enrolling patients with HF who were treated for ID with intravenous iron supplements, oral iron supplements, or Yr' placebo. The primary outcomes were all-cause death, cardiovascular mortality, and hospitalization for heart failure. The secondary outcomes were evaluated through the six-minute walking test (6MWT) and the Kansas City Cardiomyopathy Questionnaire (KCCQ).
Results
The network meta-analysis included sixteen studies. Compared to placebo/control groups, intravenous iron supplements did not decrease all-cause death (0.69, 0.39—t.23) or cardiovascular mortality (0.89, 0.66-1.2o). After 12 weeks, a reduced
We aimed at comparing the efficacy of intravenous and oral iron supplementations for the treatment of iron deficiency (ID) in patients with heart failure (HF).
Adverse Event
Symptoms
Disease
Time
Severity
Outcome
Clinical Researchers:
Focus on the Science,
let AI do the rest
Get Started
Harness the power of AI to generate compliant life sciences content and drive willingness to offer
Brainstorming and
Study Design
Extract intelligence from information in seconds
Flexible tools to brainstorm
AI generation of content with context
Can be imported and used to write papers in minutes
Cilnimet
Cilnidipine 10mg. Tablet
Improves glucose and lipid metabolism in patients with hypertension
Relaxes human arteries through Ca2+ channel antagonism and enhanced nitric oxide production
Resolves amlodipine-induced ankle edema without worsening hypertension
Hypertensive & Cardiovascular Disease
Diabetes Mellitus
Renal Disease
Efficacy
Cilnimet
Cilnidipine 10mg. Tablet
Comorbidities
Improves left ventricular midwall function independently of blood pressure changes
Controls blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis.
Improve insulin sensitivity in patients with essential hypertension and Type II diabetes
Hypertensive & Cardiovascular Disease
Diabetes Mellitus
Renal Disease
Select HCP Persona
Efficacy
Adverse Reactions
Comorbidities
Cost of Treatment
Generate
TESTIMONIALS
What customers say
Innovation Team Head
Merck
“Creating dynamic compliant content for different HCP personas is where the secret sauce is”
Medical Affairs Head
J&J
“I now create my first draft in minutes - saves me a couple of months of back and forth"
Business Unit Director
Abbott
“ Automating our brand guidelines audit has been a life saver. We have drastically increased our adherence rates with LogicFlo ”
Business Unit Director
Abbott
“ Automating our brand guidelines audit has been a life saver. We have drastically increased our adherence rates with LogicFlo ”
Compliance
Generate and manage compliance reporting with minimal manual effort
Brand Guidelines adherence + regulatory and policy requirements
Veracity of medical claims and safety information with source literature
Tonality and identity of collateral
Cilnimet
Cilnidipine 10mg. Tablet
Cilnidipine helps with headache
Invalid Claim!
Reason: No studies related to headaches
Suggestion: Cilnidipine is effective in reducing heart rate
Cilnidipine helps with headache
Invalid Claim!
Reason: No mention of D-type calcium blocker
Suggestion: Novel calcium antagonist with L/N type channel blocker
Possesses superior selectivity for vascular smooth muscle cells
Novel calcium antagonist accompanied with L-type and N-type calcium channel blocking function
Manuscript Generation
Write journal-grade research papers in seconds
Breakthrough response time driving WTO with HCPs
Automatically receive query and retrieve relevant insights from scientific literature
Automatically draft responses with relevant info and links to source docs ready to go
Track and Analyze
Dear Dr Ackerman,
Thank you for your query. In patients with benign nephrosclerosis, Cilnidipine has been effective in controlling blood pressure and proteinuria and can be used safely. Attached is a journal article with relevant studies done in patients with nephrosclerosis. Please let me know if I can assist you further
Regards,
Dr Gassner
Explore user guide
BioSynta Labs
Dr Ackerman from New jersey
I have a hypertensive patient who also has benign nephrosclerosis.
Can I prescribe Cilnidipine safely?
Generate response
Contact us
Get in touch with us
Our team will get back to you
Copyright © 2024 Logicflo.ai, All rights reserved.